|
× |
 |
Editorial: Moving Forward PDF |
$40.00 |
|
$40.00 |
|
× |
|
Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Three-Month Follow-up Study of Mental Health Outcomes After a National COVID-19 Lockdown: Comparing Patients With Mood or Anxiety Disorders Living in an Area With a Higher Versus Lower Infection Incidence PDF |
$40.00 |
|
$40.00 |
|
× |
|
Switching From Clozapine to Olanzapine in Treatment-Refractory Schizophrenia: Safety, Clinical Efficacy, and Predictors of Response PDF |
$40.00 |
|
$40.00 |
|
× |
|
Bipolar Symptoms in Adult Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study of 510 Clinically Diagnosed Patients and 417 Population-Based Controls PDF |
$40.00 |
|
$40.00 |
|
× |
|
Disulfiram Use in Patients With Abnormal Liver Function Test Results PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antidepressant Discontinuation and Risk of Suicide Attempt: A Retrospective, Nested Case-Control Study PDF |
$40.00 |
|
$40.00 |
|
|
